Abstract

Background: Carcinoma cervix is most common carcinoma among middle and low socioeconomic countries due to,illiteracy and unhygienic conditions. Objectives: The objectives of the study were to evaluate the response and outcome,of radiotherapy along with cisplatin as chemotherapy in carcinoma cervix Stage II B–IV.
Materials and Methods: This,is a prospective analytical study on 93 patients for 2 years in tertiary care hospital.
Results: In the present study diseasefree,survival rate at 1 year after treatment was 72.04%. Follow-up was in the range of 4–18 months. In the present study,,overall survival rate at 1 year after treatment was 77.4%. In our study, of 93 patients, 21 patients succumbed to death at,the end of 1 year. Among them, 10 patients (47.61%) died due to acute renal failure and rest died due to cardiorespiratory,failure. Conclusion: Conventional fractionation radiotherapy holds its utility in terms of efficacy and safety profile in the,management of carcinoma cervix. The use of External Beam Radiation Therapy with chemotherapeutic drugs, i.e., cisplatin,has showed high compliance to radiotherapy.